Metabolic features and glucocorticoid-induced comorbidities in patients with giant cell arteritis and polymyalgia rheumatica in a Dutch and Danish cohort.

Idil Esen,Suzanne Arends,Berit Dalsgaard Nielsen,Philip Therkildsen,Ib Hansen,Anna van 't Ende,Peter Heeringa,Annemieke Boots,Ellen Hauge,Elisabeth Brouwer,Yannick van Sleen

RMD open（2023）

Cited 2|Views19

No score

Abstract

Data from the GCA and PMR cohorts imply a metabolic dysregulation in treatment-naïve patients with GCA, but not in patients with PMR. Treatment with GCs led to the rise of comorbidities and an unhealthier metabolic profile, stressing the need for prednisone-sparing targeted treatment in these vulnerable patients.

Translated text

Key words

Giant Cell Arteritis,Glucocorticoids,Polymyalgia Rheumatica

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined